botensilimab,balstilimab
agenus
bot is an fc enhanced ctla-4 inhibitor, designed to extend the benefits of i-o to cold tumors which are traditionally unresponsive to immunotherapies &amp; reduce complement mediated toxicity. #esmogi
Our goal is to treat cancers with novel combinations using our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines & adjuvants